Yüklüyor......
Development and Use of Integral Assays in Clinical Trials
Clinical trials that include integral biomarkers to determine eligibility, assign treatment or assess outcome must employ robust assays to measure the molecular analyte of interest. The decision to develop a biomarker assay into a test suitable for use in humans should be driven by clinical need, i....
Kaydedildi:
| Asıl Yazarlar: | , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2012
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3307146/ https://ncbi.nlm.nih.gov/pubmed/22422406 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-11-2202 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|